摘要
3,4-二羟基苯甲醛与二氟一氯甲烷醚化得到3-羟基-4-二氟甲氧基苯甲醛,与氯甲基环丙烷醚化得到3-环丙基甲氧基-4-二氟甲氧基苯甲醛,再经氧化、氯代后与4-氨基-3,5-二氯吡啶反应,制得慢性阻塞性肺病治疗药罗氟司特,总收率约23%。
Roflumilast, an anti-chronic obstructive pulmonary disease (COPD) drug, was synthesized from 3,4- dihydroxybenzaldehyde via etherification with chlorodifluoromethane to give 3-hydroxy-4-difluoromethoxybenzaldehyde, which was subjected to etherification with chloromethylcyclopropane to give 3-eyclopropylmethoxy-4-difluoro- methoxybenzaldehyde, followed by oxidation, chlorination and then reaction with 4-amino-3,5-dichloropyridine with an overall yield of about 23 %.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2011年第12期884-886,共3页
Chinese Journal of Pharmaceuticals
关键词
罗氟司特
慢性阻塞性肺病
合成
roflumilast
chronic obstructive pulmonary disease
synthesis